Document:

ex10-58.htm

    

    EXHIBIT
10.58

    

    EMPLOYMENT
TRANSITION AGREEMENT AND RELEASE

    

    

    United
Natural Foods, Inc., a Delaware corporation (the “Company”) and Richard
Antonelli (“Mr. Antonelli”) hereby agree as follows:

    

    
      	
              1.

            	
              Mr.
      Antonelli hereby resigns as (i) an employee and officer of the Company,
      (ii) a member of the Board of Directors of the Company and (iii) an
      officer and director of any subsidiaries of the Company where he holds
      such offices, effective August 12, 2008, although Mr. Antonelli may choose
      to resign on an earlier date (the “Resignation Date”).  Mr.
      Antonelli shall remain on a paid leave of absence with the Company through
      the Resignation Date; such leave shall not serve to reduce Mr. Antonelli’s
      accrued vacation.

            

    

    

    
      	
              2.

            	
              On
      the Resignation Date, the Company will pay Mr. Antonelli for any unused
      vacation time earned by him through the Resignation Date. Beginning with
      the later of the Resignation Date or the expiration of the Revocation
      Period (as hereinafter defined):

            

    

    

    
      	
               
      

            	
              a.
      The Company shall honor its obligations to Mr. Antonelli under Section 2
      of the Severance Agreement dated as of July 25, 2005 between the Company
      and Mr. Antonelli (the “Severance Agreement”), under which the Company
      shall continue Mr. Antonelli’s base salary and medical benefits for a
      period of one (1) year, subject to applicable withholding and deductions,
      provided, however that the Company shall make no base salary payments
      under this Section 2(a) until six months and one day after the Company’s
      obligations commence, at which point the Company shall pay Mr. Antonelli
      all accrued and unpaid base salary payments, and thereafter the Company
      shall pay base salary for the balance of the one-year period in accordance
      with its normal payroll policies.

            

    

    

    
      	
               
      

            	
              b.
      After the expiration of the above-referenced one-year period, the Company
      shall respect Mr. Antonelli’s rights (and his dependents’ rights), if any,
      to continued medical coverage at his own expense under the Consolidated
      Omnibus Budget Reconciliation Act.

            

    

    

    
      	
              3.

            	
              a.
      As of the Resignation Date, Mr. Antonelli shall no longer be eligible to
      receive long-term disability benefits or to participate in the Company’s
      401(k) and Profit Sharing Plan.  The Company will promptly
      notify Mr. Antonelli in writing concerning his options with regard to his
      401(k) account.

            

    

     

    
      
         

      

      
         

         

      

      
         

      

    

    
      	
               
      

            	
              b.
      As of the Resignation Date: (i) Mr. Antonelli’s ability to exercise any
      vested stock options to purchase shares of the Company’s Common Stock
      shall be governed by the terms of the applicable equity plan and (ii) all
      unvested stock options shall be forfeited, except for those restricted
      stock units (“RSUs”) and restricted shares of Common Stock that were due
      to vest in December of 2008, and will now accelerate to vest as of the
      Resignation Date.  Only those restricted shares and restricted
      stock units shall be vested and exercisable in addition to the stock
      options noted in (i) above and shall be governed by the terms of the
      applicable plan.  The Company will promptly notify Mr. Antonelli
      in writing concerning his ability to exercise any vested stock options,
      RSUs or restricted shares of Common
Stock.

            

    

    

    
      	
               
      

            	
              c.
      Mr. Antonelli may at any time exercise his rights under the Company’s
      Employee Stock Ownership Plan (“ESOP”) to effect the distribution and
      sale, if he so elects, of shares of the Company’s Common Stock allocated
      to him, in accordance with the provisions of the
  ESOP.

            

    

    

    
      	
              4.

            	
              a.  In
      consideration of the foregoing, which Mr. Antonelli acknowledges includes
      compensation, benefits and other rights to which he is not otherwise
      entitled, Mr. Antonelli hereby releases and forever discharges the
      Company, its present and former directors, officers, employees, agents,
      subsidiaries and shareholders, and its and their successors and assigns,
      from any and all liabilities, causes of action, debts, claims and demands
      (including without limitation claims and demands for monetary payment)
      both in law and in equity, known or unknown, fixed or contingent, which he
      may have or claim to have based upon or in any way related to: (i)
      employment (as an officer, director or employee), (ii) any rights or
      entitlements related thereto or (iii) termination of such employment by
      the Company, and hereby covenants not to file a lawsuit or charge to
      assert such claims.  This includes but is not limited to claims
      arising under the Federal Age Discrimination in Employment Act, and any
      other federal, state or local laws prohibiting employment discrimination
      or claims growing out of any legal restrictions on the Company’s right to
      terminate its employees

            

    

    

    
      	
               
      

            	
              b.
      Mr. Antonelli understands that various State and Federal laws prohibit
      employment discrimination based on age, sex, race, color, national origin,
      religion, handicap or veteran status.  These laws are enforced
      through the Equal Employment Opportunity Commission (EEOC), Department of
      Labor and State Human Rights Agencies.  Mr. Antonelli
      acknowledges that he has been advised by the Company to discuss this
      Agreement with his attorney and has been encouraged to take this Agreement
      home for up to twenty-one (21) days so that he can thoroughly review it
      and understand the effect of this Agreement before acting on
      it.

            

    

    

    
      
         

      

      
        2

         

      

      
         

      

    

    
      	
              5.

            	
              a.
      Mr. Antonelli acknowledges and agrees that all payments and benefits
      payable to him under this Agreement (other than earned wages and payment
      for accrued and unpaid vacation) are contingent upon: (i) his continued
      compliance with the provisions of Section 6 of the Severance Agreement,
      which remain in full force and effect and (ii) his agreement to make
      himself available in any third party claims, investigations, litigation or
      similar proceedings to answer any questions relating to his employment or
      actions as an employee, officer or director of the Company, including
      without limitation attendance at any deposition or similar proceeding, and
      the Company shall pay Mr. Antonelli’s expenses in connection with his
      fulfillment of his obligations under this subsection
  (ii).

            

    

    

    
      	
               
      

            	
              b.
      Mr. Antonelli further acknowledges and agrees that the availability of
      such payments and benefits is sufficient consideration for the release set
      forth in paragraph 4(a) and termination of such payments and benefits due
      to his non-compliance shall not affect the release set forth in Paragraph
      4(a).

            

    

    

    
      	
              6.

            	
              Mr.
      Antonelli shall at no time make any derogatory or disparaging comments
      regarding the Company, its business, or its present or past directors,
      officers or employees.  The Company shall at no time make any
      derogatory or disparaging comments regarding Mr. Antonelli.  Mr.
      Antonelli hereby waives any and all rights to future employment with the
      Company.

            

    

    

    
      	
              7.

            	
              The
      execution of this Agreement shall not be construed as an admission of a
      violation of any statute or law or breach of any duty or obligation by
      either the Company or Mr.
Antonelli.

            

    

    

    
      	
              8.

            	
              No
      party to this Agreement shall cause, discuss, cooperate or otherwise aid
      in the preparation of any press release or other publicity other than
      filings required by the securities laws, concerning any other party to
      this Agreement or the Agreement’s operation without prior approval of such
      other party, unless required by law, in which case notice of such
      requirement shall be given to the other
party.

            

    

    

    
      	
              9.

            	
              The
      invalidity or unenforceability of any particular provision of this
      Agreement shall not affect the other provisions hereof, and this Agreement
      shall be construed in all respects as if such invalid and unenforceable
      provisions were omitted.

            

    

    

    
      	
              10.

            	
              This
      Agreement is personal to Mr. Antonelli and may not be assigned by
      him.  However, in the event of Mr. Antonelli’s death, all the
      rights of Mr. Antonelli set forth in this Agreement shall accrue to his
      spouse, if she is living; otherwise, to his heirs.  This
      Agreement shall inure to the benefit of and be binding upon the successors
      and assigns of the Company.

            

    

    

    
      
         

      

      
        3

         

      

      
         

      

    

    
      	
              11.

            	
              This
      Agreement is made pursuant to and shall be governed by the laws of the
      State of Connecticut, without regard to its rules regarding conflict of
      laws.  The parties agree that the courts of the State of
      Connecticut, and the Federal Courts located therein, shall have exclusive
      jurisdiction over all matters arising from this Agreement.  Mr.
      Antonelli and the Company hereby agree that service of process by
      certified mail, return receipt requested, shall be deemed appropriate
      service of process.

            

    

    

    
      	
              12.

            	
              Except
      as otherwise expressly indicated, this Agreement contains the entire
      understanding between Mr. Antonelli and the Company, supersedes all prior
      agreements, oral or written, regarding the subject matter hereof, and may
      not be changed orally but only by an agreement in writing signed by the
      party against whom enforcement of any waiver, change, modification,
      extension or discharge is sought.  Mr. Antonelli acknowledges
      that he has not relied upon any representation or statement, written or
      oral, not set forth in this
Agreement.

            

    

    

    
      	
              13.

            	
              Mr.
      Antonelli may revoke this Agreement at any time during the seven-day
      period following the date of his signature below (the “Revocation Period”)
      by delivering written notice of his revocation to the Company’s attention
      at 260 Lake Road, Dayville, Connecticut 06241; Attention: Carl
      Koch.  This Agreement shall become effective upon the expiration
      of the Revocation Period.

            

    

    

    [signature
lines appear on the next page]

    

    
      
         

      

      
        4

         

      

      
         

      

    

    

    IN
WITNESS WHEREOF, the parties have executed this Agreement on the date set forth
below.

    

    
      	
              United
      Natural Foods, Inc.

            	 
      	
              Witness:

            
	 
      	 
      	 
      
	 
      	 
      	 
      
	
              By:
      /s/ Daniel V. Atwood    

            	 
      	
              /s/
      Lisa N'Chonon    

            
	 
      	 
      	 
      
	
              Date:
      August 6, 2008

            	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	
              Witness:

            
	 
      	 
      	 
      
	
              /s/ Richard
      Antonelli    

            	 
      	
              /s/
      Carl F. Koch III    

            
	
              Richard
      Antonelli

            	 
      	 
      
	 
      	 
      	 
      
	
              Date:
      August 6, 2008

            	 
      	 
      

    

    

    

    
      
         

      

      
        5ex10-142.htm

    
      

    

    
      
        	 EXCUTION
      COPY	 	
                EXHIBIT
      10.142

              

      

       

    

    Ferring
Pharmaceuticals, Inc.

    4
Gatehall Drive, 3rd
Floor

    Parsippany,
NJ  07054

    

     

    July 8,
2008

     

    

    Vyteris,
Inc.

    13-01
Pollit Drive

    Fair
Lawn, NJ   07410

    

    Ladies
and Gentlemen:

    

    Reference
is made to (i) the License and Development Agreement dated as of September 27,
2004 (as heretofore amended, the “License Agreement”)
between Ferring Pharmaceuticals, Inc. (“Ferring”) and
Vyteris, Inc. (“Vyteris”), and (ii)
the Supply Agreement dated September 27, 2004 (the “Supply Agreement”)
between Ferring and Vyteris.

     

    On the
date hereof, at the request of Vyteris, Ferring is making a loan to Vyteris in
the principal amount of $2,500,000.00 (the “Loan”) evidenced by a
Secured Note dated the date hereof and secured by a security interest in certain
collateral (the “Collateral”) granted
by Vyteris to Ferring under the Security Agreement dated as of the date hereof
(the “Security
Agreement”) between Vyteris and Ferring.  As additional
consideration for, and in order to induce Ferring to make, the Loan, Vyteris and
Ferring hereby agree as follows:

    
    

     

        1.    Vyteris hereby
agrees that the proceeds of the Loan shall be used only to pay for Vyteris’
payment obligations under the License Agreement and the Supply Agreement and for
other essential corporate operating expenses, including, but not limited to, any
expenses attributable to Vyteris incur with shipment (and related matters) of
the Equipment to Borrower’s Facility subject to paragraph 8 hereof.

     

    
    

        2.    Section
2.01(a) of the License Agreement is hereby amended to (a) insert the words
“irrevocable (subject only to Ferring’s fulfillment of its obligations under the
License Agreement)” immediately before the word “exclusive” in the first line
thereof and (b) insert the words “have manufactured,” immediately after the word
“manufacture” in the second and fourth lines thereof.

    
    

     

        3.    Section 2.02
of the License Agreement is hereby amended to insert the following as new
paragraphs at the end thereof:

     

    “The
parties acknowledge that Ferring is now entitled to the benefits of the
immediately preceding paragraphs of this Section 2.02 as if the conditions set
forth therein have been satisfied as of the date hereof and Vyteris shall use
its reasonable best efforts to effectuate the foregoing provisions of this
Section 2.02 and cooperate with Ferring in all reasonable respects related
thereto solely by the prompt transmittal to Ferring of copies of all
manufacturing Know How existing as of the date hereof.  Vyteris makes
no representations to Ferring with regard to such documentation, and Vyteris has
no further obligations to Ferring regarding the manufacturing
Know-How”.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    “Notwithstanding
anything to the contrary contained herein, Vyteris hereby grants Ferring the
irrevocable right, at Ferring’s election which may be exercised at any time, to
make or have made the Product (by Ferring itself, its sublicensee(s) and/or by a
third party selected by Ferring) to provide supplies of the Product for Phase
III trials and/or for commercial supply of the Product for marketing and sale by
Ferring and/or its affiliates and sublicensees hereunder.  This right
shall survive termination of this Agreement and continue thereafter so long as
Ferring has the license to market and sell the Product hereunder.”

    
    

     

        4.    Section 9.07
of the License Agreement is hereby amended to change the words “shall grant”
appearing in clause (c) thereof to “hereby grants” and by adding after the word
“irrevocable” the following “(subject to performance by Ferring of its
obligations hereunder including any payment obligations)”..

    
    

     

    
    

        5.    The License
Agreement is hereby amended to insert the following new Section 21 at the end
thereof:

     

    
    

    
      
        “21.    ACKNOWLEDGEMENT

         

      

    

    
    

    
      
        21.01    The
parties hereto acknowledge that this Agreement is a license of intellectual
property within the meaning of 11 U.S.C. §365(n).”

         

      

    

    
    

        6.    Article 5 of
the Supply Agreement is hereby amended to add the following as a new paragraph
at the end thereof:

     

    “Notwithstanding
the foregoing, Vyteris hereby grants Ferring the  right, which may be
exercised at any time, to establish an additional source or sources to
manufacture and supply or to have manufactured and supplied the Product to
Ferring (such  manufacturing to be performed by Ferring itself, its
sublicensee(s) and/or by a third party selected by Ferring).  This
right is granted solely with respect to manufacture of the Product and is
limited in all respects by the applicable provisions of the License
Agreement.  This right shall survive termination of this Agreement and
continue thereafter so long as Ferring has the license to market and sell the
Product under the License and Development Agreement.”

    
    

     

    
    

        7.    Vyteris
hereby agrees to furnish to Ferring no later than July 1, 2008, copies of all
Form FDA 483 Inspectional Observations (“FDA 483s”) existing
as of such date and related to Vyteris’ manufacturing activities which
could reasonably affect the Product and any like FDA 483s until the Loan is
repaid in full.. and until the Loan is repaid in full, to furnish to Ferring,
promptly upon receipt, copies of all FDA 483s relating to the Product after the
date hereof.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    
          8.    Until the Loan
is repaid in full, Vyteris may not make any payments to any related party
shareholders or entities controlled by related party shareholders (“related
party shareholder” is defined as those shareholders listed on the “SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT” table in Vyteris’
Schedule 14A filed with the SEC on April 25, 2008), except for salaries,
bonuses, benefits, etc. and consulting fees payable to officers as set forth on
Exhibit A hereto (subject to customary increases for inflation and the like)and
Russell Potts and Arthur Courbanou (directors) at ongoing rates and otherwise,
as such compensation packages may be amended upon terms no more favorable to
such officers and director than under past practice approved by Vyteris’
compensation committee.  Notwithstanding anything to the contrary in
the foregoing, this paragraph 8 shall not prohibit payment by Vyteris to its
directors under the 2007 Outside Directors Compensation Plan, as may be amended
from time to time.

    

     

        9.    So long as any
amounts are outstanding under the Note, Ferring shall receive notice of all
meetings  of the Board of Directors of Vyteris, and subject to having
designated an observer (which may be only one person and not subject to change
unless the designated person is no longer employed or retained by Ferring), who
has signed Vyteris’ standard nondisclosure agreement , such observer may attend
Vyteris’ meetings of its Board of Directors ; provided, however, that such
observer shall not have a right to vote or otherwise pass on any matters brought
to the attention of the Board at such meetings, and such observer shall be
excluded from any discussions regarding any matters related to
Ferring.  The observer also covenants that he will not share any
material discussed at any Board meeting with any third party or related party
including Ferring and its affilaites.

     

        10.    This letter agreement
shall be governed by and construed in accordance with the laws of the State of
New York without giving effect to conflicts of law principles.

    
      
      

     

        11.    This letter agreement
may be executed in counterparts and delivered by facsimile, each of which shall
be deemed an original, but all of which together shall constitute one and the same
instrument.  Vyteris and Ferring hereby submit to the exclusive
jurisdiction of the state and federal courts located in the City of Newark,
State of New Jersey for the sole purpose of this letter agreement and any
controversy arising hereunder. VYTERIS AND

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    FERRING
EACH WAIVE THEIR RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING
FROM THIS LETTER AGREEMENT.

     

    Please
confirm your agreement to the foregoing by executing the enclosed duplicate
original of this letter in the space provided below and returning it to
Ferring.

     

    
      
        	 	FERRING
      PHARMACEUTICALS, INC.	 
	 	 	 	 
	
                 

              	
                By:
      

              	/s/
      Wayne C. Anderson	 
	 	 	Name:
      Wayne C. Anderson	 
	 	 	Title:
      President and CEO	 
	 	 	 	 

      

    

     

    ACCEPTED
AND

    AGREED
TO:

    

    

    VYTERIS,
INC.

    

    

    By:   _/s/
Donald Farley

    Name:
Donald Farley

    Title:
Chairman

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
A

    

    OFFICER
COMPENSATION

    

    
      	
              Name

            	 	
              Annual

               Salary

            	 	 	
              Contract

               Term

            	 	 	
              Options
      

              50%
      Grant

               &
      50% 

              Performance

              Vest
      

              Annually

               over
      2 years

            	 	 	
              Cash
      

              Bonus

               Performance

               Based
      

              as
      % of 

              Base
      

              Salary

            	 	
              Severance
      

              Base

               Pay
      & 

              Benefits

            	
              Severance

              Options
      

              Extend

               Vesting

            	
               

               

               

               

               

               

              Other

               

            
	
              Espinal,
      Rafael

            	 	$	240,000	 	 	 	N/A	 	 	 	400,000	 	 	 	20	%	 
      	 
      	
              $800
      Car

               Allowance
      &

              $3,500
      rent

               per
      month

               12/31/2008

            
	
              Lyons,
      Cormac

            	 	$	173,250	 	 	
              2
      year

            	 	 	 	400,000	 	 	 	20	%	
              6
      months

            	
              2
      years

            	 
      
	
              Reidy,
      Mike

            	 	$	172,575	 	 	
              2
      year

            	 	 	 	400,000	 	 	 	20	%	
              6
      months

            	
              2
      years

            	 
      
	
              Himy,
      Joseph

            	 	$	192,000	 	 	
              2
      year

            	 	 	 	1,000,000	 	 	 	25	%	
              6
      months

            	
              2
      years

            	 
      
	
              Hartounian,
      Haro

            	 	$	325,000	 	 	
              2
      year

            	 	 	 	2,500,000	 	 	 	40	%	
              6
      months

            	
              2
      years

            	
              $10K
      a 

              month
      living

               Expense
      

              through
      June 

              2009

            
	
              Farley,
      Don

            	 	
              $30,000
      

              remaining

               at
      

              $2,000in
      

              cash
      per

               week;
      if 

              extension,

               would
      be 

              at
      $2,000 

              in
      cash 

              per
      week

            	 	 	 	 	 	 	 	 	 	 	 	 	 	 
      	 	
              $500
      in stock for 20 weeks;

               

               

               

               

               

               

               

               

            

    

    

    

    

    5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}]]